Global Diagnostic Imaging Market was valued at USD XX Billion in the year 2021. Global Diagnostic Imaging Market is further estimated to grow at a CAGR of XX% from 2022 to 2030 it will reach USD XX Billion by the year 2030. The North America region holds the highest market share in 2021 and the Asia Pacific is considered as the fastest growing market in the forecasted period. At a country level, US, China are projected to grow strongly in the coming years due to increasing density of population and funding through Research and Development.
The Global Diagnostic Imaging Report 2022-2030 covers market opportunities and challenges, key market regulations’ information, analysis of new products from the market players and key market trends, market share analysis for key players, supply chain and value chain analysis, product and Material trends, pricing analysis, emerging applications, technologies and major recent developments. This information has also been provided for the major country markets in these regions. Market shares, size and growth potential are assessed for these major country markets. Market opportunities, challenges, government regulations, market share analysis by major competitors, recent major market developments (product launches, M&A, partnerships, etc.) and other information have been covered for the major country markets listed in this section.
On the basis of Type, the market is divided as MRI (Open, Closed), Ultrasound (2D, 4D, Doppler), CT, X-Ray (Digital, Analog), SPECT, Hybrid PET, Mammography. In which MRI for the largest market share due to increasing demand in future market trends. Regional breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and ROW.
Market player analysis of major companies such as GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Agfa-Gevaert N.V., Canon Medical Systems Corporation, Hitachi Ltd., Carestream Health, Inc., Esaote S.p.A, Hologic, Inc., FUJIFILM Holdings Corporation, Samsung Electronics, Mindray Medical International, Planmed Oy, CurveBeam LLC, Shimadzu Corporation...

1 INTRODUCTION
1.1 OBJECTIVES
1.2 RESEARCH METHODOLOGY
1.2.1 SECONDARY DATA
1.2.2 PRIMARY DATA
1.2.3 MARKET SIZE ESTIMATION
1.2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
1.3 STAKEHOLDERS
1.4 RESEARCH ASSUMPTIONS
1.5 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 OPPORTUNITIES MATRIX
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 VALUE CHAIN ANALYSIS
3.6 DEMAND SIDE ANALYSIS
3.7 SUPPLY SIDE ANALYSIS
3.8 PORTER’S FIVE FORCES MODEL
3.8.1 DEGREE OF COMPETITION
3.8.2 BARGAINING POWER OF BUYERS
3.8.3 BARGAINING POWER OF SUPPLIERS
3.8.4 THREAT FROM SUBSTITUTES
3.8.5 THREAT FROM NEW ENTRANTS
4 INDUSTRY TRENDS
4.1 PRODUCT LIFE CYCLE
4.2 NEW MARKET ENTRY STRATEGY
4.3 PESTEL ANALYSIS
4.4 PRICING ANALYSIS
4.5 TRADE DATA
4.6 TECHNOLOGICAL OVERVIEW
4.7 FUTURE OUTLOOK MARKET TRENDS
4.8 MACRO-ECONOMIC VARIABLES (DEPENDENT AND INDEPENDENT VARIABLES)
4.9 MULTIFACTOR BASED SENSITIVITY ANALYSIS
4.10 REGRESSION MATRIX
4.11 COVID-19 IMPACT ANALYSES
4.12 GE MATRIX
5 DIAGNOSTIC IMAGING TYPE ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET TYPE ANALYSIS, 2016-2020
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 X-RAY IMAGING SYSTEMS
5.6 BY TECHNOLOGY
5.6.1 X-RAY DIGITAL IMAGING SYSTEMS
5.6.1.1 Direct Radiography (DR)
5.6.1.2 Computed Radiography (CR)
5.6.2 X-RAY ANALOG IMAGING SYSTEMS
5.7 BY PORTABILITY
5.7.1 STATIONARY SYSTEMS
5.7.2 PORTABLE SYSTEMS
5.8 COMPUTED TOMOGRAPHY (CT) SCANNERS
5.9 BY TECHNOLOGY
5.9.1 CONVENTIONAL CT SYSTEMS
5.9.2 CONE BEAM CT SYSTEMS (CBCT)
5.10 CONVENTIONAL CT SYSTEMS MARKET, BY TECHNOLOGY
5.10.1 HIGH-SLICE CT SCANNERS
5.10.2 MID-SLICE CT SCANNERS
5.10.3 LOW-SLICE CT SCANNERS
5.11 ULTRASOUND SYSTEMS
5.12 BY TECHNOLOGY
5.12.1 2D ULTRASOUND
5.12.2 3D AND 4D ULTRASOUND
5.12.3 DOPPLER ULTRASOUND
5.13 BY PORTABILITY
5.13.1 TROLLEY/CART-BASED ULTRASOUND SYSTEMS
5.13.2 COMPACT/PORTABLE ULTRASOUND SYSTEMS
5.14 MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS
5.15 BY ARCHITECTURE
5.15.1 CLOSED MRI
5.15.2 OPEN MRI
5.16 BY FIELD STRENGTH
5.16.1 HIGH- AND VERY-HIGH-FIELD MRI SYSTEMS
5.16.2 LOW-TO-MID-FIELD MRI SYSTEMS
5.16.3 ULTRA-HIGH-FIELD MRI SYSTEMS
5.17 NUCLEAR IMAGING SYSTEMS
5.18 SPECT SYSTEMS
5.18.1 STANDALONE SPECT SYSTEMS
5.18.2 HYBRID SPECT SYSTEMS
5.19 HYBRID PET SYSTEMS
5.20 MAMMOGRAPHY SYSTEMS
6 DIAGNOSTIC IMAGING END USER ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET END USER ANALYSIS, 2016-2020
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 HOSPITALS
6.6 DIAGNOSTIC IMAGING CENTERS
6.7 OTHER END USERS
7 DIAGNOSTIC IMAGING MARKET APPLICATION ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 X-RAY IMAGING SYSTEMS
7.5.1 GENERAL RADIOGRAPHY
7.5.2 DENTAL
7.5.3 FLUOROSCOPY
7.6 MRI SYSTEMS
7.6.1 BRAIN & NEUROLOGICAL MRI
7.6.2 SPINE & MUSCULOSKELETAL MRI
7.6.3 VASCULAR MRI
7.6.4 PELVIC & ABDOMINAL MRI
7.6.5 BREAST MRI
7.6.6 CARDIAC MRI
7.7 ULTRASOUND SYSTEMS
7.7.1 RADIOLOGY/GENERAL IMAGING
7.7.2 CARDIOLOGY
7.7.3 OBSTETRICS/GYNECOLOGY
7.7.4 UROLOGY
7.7.5 VASCULAR
7.7.6 OTHER APPLICATIONS
7.8 CT SCANNERS
7.8.1 CARDIOLOGY
7.8.2 ONCOLOGY
7.8.3 NEUROLOGY
7.8.4 OTHER APPLICATIONS
7.9 NUCLEAR IMAGING SYSTEMS
7.9.1 CARDIOLOGY
7.9.2 ONCOLOGY
7.9.3 NEUROLOGY
7.9.4 OTHER APPLICATIONS
7.10 MAMMOGRAPHY SYSTEMS
8 GLOBAL DIAGNOSTIC IMAGING REGIONAL ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
8.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.2.3 Y-O-Y GROWTH TREND ANALYSIS
8.2.3.1 U.S.
8.2.3.2 Canada
8.2.3.3 Mexico
8.3 ASIA-PACIFIC
8.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
8.3.2 Y-O-Y GROWTH TREND ANALYSIS
8.3.2.1 China
8.3.2.2 Japan
8.3.2.3 Korea
8.3.2.4 India
8.3.2.5 Southeast Asia
8.4 MIDDLE EAST AND AFRICA
8.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
8.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.4.3 Y-O-Y GROWTH TREND ANALYSIS
8.4.3.1 Saudi Arabia
8.4.3.2 UAE
8.4.3.3 Egypt
8.4.3.4 Nigeria
8.4.3.5 South Africa
8.5 EUROPE
8.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
8.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.5.3 Y-O-Y GROWTH TREND ANALYSIS
8.5.3.1 Germany
8.5.3.2 France
8.5.3.3 UK
8.5.3.4 Russia
8.5.3.5 Italy
8.6 LATIN AMERICA
8.6.1 LATIN AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
8.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.6.3 Y-O-Y GROWTH TREND ANALYSIS
8.6.3.1 Brazil
8.6.3.2 Argentina
8.6.3.3 Columbia
9 MARKET PLAYERS
9.1 AGFA-GEVAERT N.V.
9.1.1 BUSINESS OVERVIEW:
9.1.2 PRODUCT PORTFOLIO
9.1.3 RECENT DEVELOPMENTS
9.1.4 SWOT ANALYSIS:
9.2 HITACHI LTD.
9.3 CARESTREAM HEALTH, INC.
9.4 ESAOTE S.P.A
9.5 HOLOGIC, INC.
9.6 SAMSUNG ELECTRONICS/SAMSUNG MEDISON CO., LTD.
9.7 MINDRAY MEDICAL INTERNATIONAL
9.8 PLANMED OY
9.9 CURVEBEAM LLC
9.10 SHIMADZU CORPORATION
9.11 GE HEALTHCARE
9.12 KONINKLIJKE PHILIPS N.V.
9.13 SIEMENS HEALTHINEERS
9.14 CANON MEDICAL SYSTEMS CORPORATION
9.15 BRUKER
9.16 MEDISO LTD.
9.17 MILABS B.V.
9.18 MR SOLUTIONS
9.19 TRIFOIL IMAGING
9.20 PERKINELMER INC.
9.21 FUJIFILM VISUALSONICS INC.
9.22 CUBRESA INC.
9.23 TOSHIBA MEDICAL SYSTEMS CORPORATION
10 ABOUT US

TABLE 1 DIAGNOSTIC IMAGING REGIONAL ANALYSIS, 2021–2030 (USD MILLION)
TABLE 2 GLOBAL DIAGNOSTIC IMAGING MARKET, 2021–2030, (USD MILLION)
TABLE 3 DIAGNOSTIC IMAGING CURRENT AND FUTURE REGIONAL ANALYSIS, 2021–2030 (USD MILLION)
TABLE 4 GLOBAL DIAGNOSTIC IMAGING HISTORICAL MARKET TYPE ANALYSIS, 2016-2020, (USD MILLION)
TABLE 5 DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 6 GLOBAL DIAGNOSTIC IMAGING HISTORICAL MARKET END USER ANALYSIS, 2016-2020, (USD MILLION)
TABLE 7 DIAGNOSTIC IMAGING CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 8 GLOBAL DIAGNOSTIC IMAGING HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020, (USD MILLION)
TABLE 9 DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 10 NORTH AMERICA DIAGNOSTIC IMAGING HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 11 NORTH AMERICA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 12 NORTH AMERICA DIAGNOSTIC IMAGING CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 13 NORTH AMERICA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 14 U.S. DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2016–2021
TABLE 15 U.S. DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 16 U.S. DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 17 CANADA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 18 CANADA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 19 MEXICO DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 20 MEXICO DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 21 APAC DIAGNOSTIC IMAGING HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 22 ASIA-PACIFIC DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 23 ASIA-PACIFIC DIAGNOSTIC IMAGING CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 24 ASIA-PACIFIC DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 25 CHINA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 26 CHINA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 27 JAPAN DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 28 JAPAN DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 29 KOREA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 30 KOREA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 31 INDIA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 32 INDIA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 33 SOUTHEAST ASIA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 34 SOUTHEAST ASIA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA DIAGNOSTIC IMAGING HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA DIAGNOSTIC IMAGING CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 39 SAUDI ARABIA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 40 SAUDI ARABIA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 41 UAE DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 42 UAE DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 43 EGYPT DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 44 EGYPT DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 45 NIGERIA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 46 NIGERIA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 47 SOUTH AFRICA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 48 SOUTH AFRICA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 49 EUROPE DIAGNOSTIC IMAGING HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 50 EUROPE DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 51 EUROPE DIAGNOSTIC IMAGING CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 52 EUROPE DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 53 GERMANY DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 54 GERMANY DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 55 FRANCE DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 56 FRANCE DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 57 UK DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 58 UK DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 59 RUSSIA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 60 RUSSIA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 61 ITALY DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 62 ITALY DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 63 LATIN AMERICA DIAGNOSTIC IMAGING HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 64 LATIN AMERICA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 65 LATIN AMERICA DIAGNOSTIC IMAGING CURRENT AND FUTURE END USER ANALYSIS, 2021–2030 (USD MILLION)
TABLE 66 LATIN AMERICA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 67 BRAZIL DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 68 BRAZIL DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 69 ARGENTINA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 70 ARGENTINA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 71 COLUMBIA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 72 COLUMBIA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 1 GLOBAL DIAGNOSTIC IMAGING MARKET, 2021–2030, (USD MILLION)
FIGURE 2 RESEARCH METHODOLOGY
FIGURE 3 GLOBAL DIAGNOSTIC IMAGING CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 4 GLOBAL DIAGNOSTIC IMAGING CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 5 MARKET OVERVIEW
FIGURE 6 SWOT ANALYSIS
FIGURE 7 MARKET SHARE ANALYSIS
FIGURE 8 SUPPLY CHAIN ANALYSIS
FIGURE 9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 10 DIAGNOSTIC IMAGING TYPE ANALYSIS
FIGURE 11 GLOBAL DIAGNOSTIC IMAGING CURRENT AND FUTURE MARKET TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 12 DIAGNOSTIC IMAGING END USER ANALYSIS
FIGURE 13 GLOBAL DIAGNOSTIC IMAGING CURRENT AND FUTURE MARKET END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 14 DIAGNOSTIC IMAGING APPLICATION ANALYSIS
FIGURE 15 GLOBAL DIAGNOSTIC IMAGING CURRENT AND FUTURE MARKET APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 16 GLOBAL DIAGNOSTIC IMAGING CURRENT AND FUTURE MARKET VOLUME SHARE REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 17 MARKET OVERVIEW, REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 18 MARKET SHARE BY COUNTRY
FIGURE 19 NORTH AMERICA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 20 NORTH AMERICA DIAGNOSTIC IMAGING CURRENT AND FUTURE END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 21 NORTH AMERICA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 22 U.S. DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 23 U.S. DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 24 CANADA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 25 CANADA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 26 MEXICO DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 27 MEXICO DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 28 MARKET SHARE BY COUNTRY
FIGURE 29 APAC DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 30 APAC DIAGNOSTIC IMAGING CURRENT AND FUTURE END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 31 APAC DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 32 CHINA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 33 CHINA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 34 JAPAN DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 35 JAPAN DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 36 KOREA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 37 KOREA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 38 INDIA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 39 INDIA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 40 SOUTHEAST ASIA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 41 SOUTHEAST ASIA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 42 MARKET SHARE BY COUNTRY
FIGURE 43 MIDDLE EAST AND AFRICA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 44 MIDDLE EAST AND AFRICA DIAGNOSTIC IMAGING CURRENT AND FUTURE END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 45 MIDDLE EAST AND AFRICA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 46 SAUDI ARABIA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 47 SAUDI ARABIA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 48 UAE DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 49 UAE DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 50 EGYPT DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 51 EGYPT DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 52 NIGERIA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 53 NIGERIA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 54 SOUTH AFRICA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 55 SOUTH AFRICA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 56 MARKET SHARE BY COUNTRY
FIGURE 57 EUROPE DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 58 EUROPE DIAGNOSTIC IMAGING CURRENT AND FUTURE END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 59 EUROPE DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 60 GERMANY DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 61 GERMANY DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 62 FRANCE DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 63 FRANCE DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 64 UK DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 65 UK DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 66 RUSSIA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 67 RUSSIA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 68 ITALY DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 69 ITALY DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 70 MARKET SHARE BY COUNTRY
FIGURE 71 LATIN AMERICA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 72 LATIN AMERICA DIAGNOSTIC IMAGING CURRENT AND FUTURE END USER ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 73 LATIN AMERICA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 74 BRAZIL DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 75 BRAZIL DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 76 ARGENTINA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 77 ARGENTINA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 78 COLUMBIA DIAGNOSTIC IMAGING CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 79 COLUMBIA DIAGNOSTIC IMAGING CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 80 FINANCIAL OVERVIEW: